Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
3.500
+0.170 (5.11%)
At close: May 2, 2025, 4:00 PM
3.600
+0.100 (2.86%)
After-hours: May 2, 2025, 5:21 PM EDT
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $1.15 billion as of May 2, 2025. Its market cap has decreased by -65.18% in one year.
Market Cap
1.15B
Enterprise Value
882.05M
1-Year Change
-65.18%
Ranking
Category
Stock Price
$3.50
Market Cap Chart
Since October 15, 2010, Iovance Biotherapeutics's market cap has increased from $79.00M to $1.15B, an increase of 1,352.62%. That is a compound annual growth rate of 20.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 1.15B | -49.12% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 69.79% |
| Dec 31, 2014 | 217.50M | 9.63% |
| Dec 31, 2013 | 198.40M | 1,053.49% |
| Dec 31, 2012 | 17.20M | -78.23% |
| Dec 30, 2011 | 79.00M | 5.05% |
| Dec 31, 2010 | 75.20M | -4.81% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.39B |
| Johnson & Johnson | 375.64B |
| UnitedHealth Group | 364.02B |
| AbbVie | 351.09B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.09B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |